Lise Estcourt to Antiviral Agents
This is a "connection" page, showing publications Lise Estcourt has written about Antiviral Agents.
Connection Strength
0.011
-
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Med. 2021 Aug; 47(8):867-886.
Score: 0.006
-
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report. Nat Commun. 2020 12 14; 11(1):6385.
Score: 0.005